Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1999 2
2001 3
2002 1
2003 2
2004 2
2005 6
2006 1
2007 3
2008 4
2009 7
2010 5
2011 4
2012 2
2013 4
2014 3
2015 2
2016 6
2017 3
2018 5
2019 2
2020 4
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Hetland ML, Haavardsholm EA, Rudin A, Nordström D, Nurmohamed M, Gudbjornsson B, Lampa J, Hørslev-Petersen K, Uhlig T, Grondal G, Østergaard M, Heiberg MS, Twisk J, Lend K, Krabbe S, Hyldstrup LH, Lindqvist J, Hultgård Ekwall AK, Grøn KL, Kapetanovic M, Faustini F, Tuompo R, Lorenzen T, Cagnotto G, Baecklund E, Hendricks O, Vedder D, Sokka-Isler T, Husmark T, Ljoså MA, Brodin E, Ellingsen T, Söderbergh A, Rizk M, Olsson ÅR, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, van Vollenhoven R; NORD-STAR study group. Hetland ML, et al. BMJ. 2020 Dec 2;371:m4328. doi: 10.1136/bmj.m4328. BMJ. 2020. PMID: 33268527 Free PMC article. Clinical Trial.
[Combination therapy in rheumatoid arthritis].
Johnsen V, Førre Ø, Haga HJ, Kvien TK, Mikkelsen K, Nordvåg BY, Rødevand E. Johnsen V, et al. Among authors: rodevand e. Tidsskr Nor Laegeforen. 2003 May 29;123(11):1511-3. Tidsskr Nor Laegeforen. 2003. PMID: 12822010 Review. Norwegian.
[Systemic lupus erythematosus and pregnancy].
Skomsvoll JF, Aasarød K, Salvesen KA, Hoff M, Wallenius M, Rødevand E, Koksvik HS, Gilboe IM, Nossent HC. Skomsvoll JF, et al. Among authors: rodevand e. Tidsskr Nor Laegeforen. 2007 Mar 15;127(6):725-9. Tidsskr Nor Laegeforen. 2007. PMID: 17363983 Free article. Review. Norwegian.
[Reversible infertility from nonsteroidal anti-inflammatory drugs].
Skomsvoll JF, Rødevand E, Koksvik HS, Salvesen KA, von Düring V, Rygnestad T, Østensen M. Skomsvoll JF, et al. Among authors: rodevand e. Tidsskr Nor Laegeforen. 2005 Jun 2;125(11):1476-8. Tidsskr Nor Laegeforen. 2005. PMID: 15940311 Free article. Review. Norwegian.
[Takayasu's arteritis].
Rødevand E, Skomsvoll JF, Wallenius M, Henriksen AZ, Skjaerpe T, Tafjord AB. Rødevand E, et al. Tidsskr Nor Laegeforen. 2001 Jan 20;121(2):173-6. Tidsskr Nor Laegeforen. 2001. PMID: 11475193 Norwegian.
65 results